Cognitive Impairment and Atrial Fibrillation: Epidemiology, Pathophysiological Mechanisms, Risk Factors, and Future Perspectives
https://doi.org/10.51922/2616-633X.2026.10.1.2716
Abstract
Atrial fibrillation (AF) and dementia represent the most prevalent non-communicable diseases affecting the aging population posing a substantial burden on healthcare systems. For a long time, this comorbidity was attributed solely to shared risk factors. However, accumulating evidence from prospective studies indicates that AF per se is independently associated with an increased risk of cognitive impairment and dementia, even in patients without a history of stroke. This review analyzes the methodological challenges inherent in studying this relationship and synthesizes current evidence on the pathophysiological mechanisms linking AF to cognitive decline. The following pathways are examined: cerebral hypoperfusion, silent microembolization, cerebral microangiopathy, and chronic systemic inflammation. Additionally, data on the effects of various AF management strategies (anticoagulant therapy, rhythm control) on cognitive function are presented.
About the Authors
S. V. Tsimenava
Grodno State Medical University; Grodno University Hospital
Belarus
Belarus
Grodno
V. A. Snezhitskiy
Grodno State Medical University
Belarus
Belarus
Grodno
S. D. Kulesh
Grodno State Medical University; Grodno University Hospital
Belarus
Belarus
Grodno
A. I. Liabetskaya
Grodno University Hospital
Belarus
Belarus
Grodno
N. A. Bros
Grodno State Medical University
Belarus
Belarus
Grodno
References
1. Mahon S., Parmar P., Barker-Collo S. et al. Determinants, Prevalence, and Trajectory of Long-Term Post-Stroke Cognitive Impairment: Results from a 4-Year Follow-Up of the ARCOS-IV Study. Neuroepidemiology. 2017, vol. 49, pp. 129-134. DOI: 10.1159/000484606.
2. Thacker E.L., Gillett S.R., Wadley V.G. et al. The American Heart Association Life’s Simple 7 and Incident Cognitive Impairment: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. J Am Heart Assoc. 2014, vol. 3, e000635. DOI: 10.1161/JAHA.113.000635.
3. Rydén L., Zettergren A., Seidu N.M. et al. Atrial Fibrillation Increases the Risk of Dementia Amongst Older Adults Even in the Absence of Stroke. J Intern Med. 2019, vol. 286, pp. 101–110. DOI: 10.1111/joim.12902.
4. Kim D., Yang P.S., Jang E. et al. Blood Pressure Control and Dementia Risk in Midlife Patients With Atrial Fibrillation. Hypertension. 2020, vol. 75, pp. 1296–1304. DOI: 10.1161/HYPERTENSIONAHA.119.14388.
5. Banerjee G., Chan E., Ambler G. et al. Cognitive Impairment Before Atrial Fibrillation– Related Ischemic Events: Neuroimaging and Prognostic Associations. J Am Heart Assoc. 2020, vol. 9, no. 1, e014537. DOI: 10.1161/JAHA.119.014537.
6. Papanastasiou C.A., Theochari C.A., Zareifopoulos N. et al. Atrial Fibrillation Is Associated With Cognitive Impairment, All-Cause Dementia, Vascular Dementia, and Alzheimer’s Disease: A Systematic Review and Meta-Analysis. J Gen Intern Med. 2021, vol. 36, no. 10, pp. 3122–3135. DOI: 10.1007/s11606-021-06954-8.
7. Wu Y.T., Fratiglioni L., Matthews F.E. et al. Dementia in Western Europe: Epidemiological Evidence and Implications for Policy Making. Lancet Neurol. 2016, vol. 15, no. 1, pp. 116–124. DOI: 10.1016/S1474-4422(15)00092-7.
8. Parfenov V.A. Combination and mutual effect of Alzheimer’s disease and cerebrovascular disease. Medical council. 2019, no 9, pp. 8-13. (in Russian).
9. Mityaeva E.V., Kamchatnov P.R., Osmaeva Z.Kh. Cognitive impairment in patients with atrial fibrillation. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2023, vol. 123, no 8, pp. 12-20. (in Russian).
10. Zoni-Berisso M., Lercari F., Carazza T. et al. Epidemiology of Atrial Fibrillation: European Perspective. Clin Epidemiol. 2014, vol. 6, pp. 213–220. DOI: 10.2147/CLEP.S47385.
11. Dietzel J., Haeusler K.G. Does Atrial Fibrillation Cause Cognitive Decline and Dementia? Europace. 2018, vol. 20, no. 3, pp. 408–419. DOI: 10.1093/europace/eux031.
12. Chen Y., Szoeke C., Woodward M. Performance of the Different Proposed Criteria for the Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease: Data From the Australian Imaging, Biomarkers and Lifestyle Study of Aging. Alzheimers Dement. 2013, vol. 9, no. 4, pp. 755–756. DOI: 10.1016/j.jalz.2013.04.080.
13. Svennberg E., Engdahl J., Al-Khalili F. et al. Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study. Circulation. 2015, vol. 131, pp. 2176–2184. DOI: 10.1161/CIRCULATIONAHA.114.014343.
14. Sanna T., Diener H.C., Passman R.S. et al. Cryptogenic Stroke and Underlying Atrial Fibrillation. N Engl J Med. 2014, vol. 370, no. 26, pp. 2478–2486. DOI: 10.1056/NEJMoa1313600.
15. Chen L.Y., Norby F.L., Gottesman R.F. et al. Association of Atrial Fibrillation With Cognitive Decline and Dementia Over 20 Years: The ARIC-NCS (Atherosclerosis Risk in Communities Neurocognitive Study). J Am Heart Assoc. 2018, vol. 7, no. 6, e007301. DOI: 10.1161/JAHA.117.007301.
16. Marzona I., O’Donnell M., Teo K. et al. Increased Risk of Cognitive and Functional Decline in Patients With Atrial Fibrillation: Results of the ONTARGET and TRANSCEND Studies. CMAJ. 2012, vol. 184, no. 6, pp. E329–E336. DOI: 10.1503/cmaj.111173.
17. Thacker E.L., McKnight B., Psaty B.M. et al. Atrial Fibrillation and Cognitive Decline: A Longitudinal Cohort Study. Neurology. 2013, vol. 81, no. 2, pp. 119–125. DOI: 10.1212/WNL.0b013e31829a33d1.
18. Saglietto A., Matta M., Gaita F. et al. Stroke-Independent Contribution of Atrial Fibrillation to Dementia: A Meta-Analysis. Open Heart. 2019, vol. 6, no. 1, e000984. DOI: 10.1136/openhrt-2018-000984.
19. Haeusler K.G., Wilson D., Fiebach J.B. et al. Brain MRI to Personalise Atrial Fibrillation Therapy: Current Evidence and Perspectives. Heart. 2014, vol. 100, no. 18, pp. 1408–1413. DOI: 10.1136/heartjnl-2013-305151.
20. Manolis T.A., Manolis A.A., Apostolopoulos E.J. et al. Atrial Fibrillation and Cognitive Impairment: An Associated Burden or Burden by Association? Angiology. 2020, vol. 71, no. 6, pp. 498–519. DOI: 10.1177/0003319720910669.
21. Nakase T., Tatewaki Y., Thyreau B. et al. Impact of Atrial Fibrillation on the Cognitive Decline in Alzheimer’s Disease. Alzheimers Res Ther. 2023, vol. 15, no. 1, art. 15. DOI: 10.1186/s13195-023-01190-0.
22. Graff-Radford J., Madhavan M., Vemuri P. et al. Atrial Fibrillation, Cognitive Impairment, and Neuroimaging. Alzheimers Dement. 2016, vol. 12, no. 4, pp. 391–398. DOI: 10.1016/j.jalz.2015.08.164.
23. Alosco M.L., Spitznagel M.B., Sweet L.H. et al. Atrial Fibrillation Exacerbates Cognitive Dysfunction and Cerebral Perfusion in Heart Failure. Pacing Clin Electrophysiol. 2015, vol. 38, no. 2, pp. 178–186. DOI: 10.1111/pace.12543.
24. Junejo R.T., Braz I.D., Lucas S.J. et al. Neurovascular Coupling and Cerebral Autoregulation in Atrial Fibrillation. J Cereb Blood Flow Metab. 2020, vol. 40, no. 8, pp. 1647–1657. DOI: 10.1177/0271678X19870770.
25. Snezhitskiy V., Bubeshka The Role of Inflammation in the Pathogenesis of Atrial Fibrillation. Cardiology in Belarus. 2015, no 4, pp. 129-138. (in Russian).
26. Mhatre-Winters I., Eid A., Han Y. et al. Sex and APOE Genotype Alter the Basal and Induced Inflammatory States of Primary Astrocytes from Humanized Targeted Replacement Mice. ASN Neuro. 2023, vol. 15, 17590914221144549. DOI: 10.1177/17590914221144549.
27. Bunch T.J., May H., Cutler M. et al. Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients with Non-Valvular Atrial Fibrillation. J Arrhythm. 2022, vol. 38, no. 6, pp. 997–1008. DOI: 10.1002/joa3.12781.
28. Cadogan S.L., Powell E., Wing K. et al. Anticoagulant Prescribing for Atrial Fibrillation and Risk of Incident Dementia. Heart. 2021, vol. 107, no. 23, pp. 1898–1904. DOI: 10.1136/heartjnl-2021-319672.
29. Wang X., Wang Z., Yan X. [et al.]. Radiofrequency and Cryoballoon Ablation Improve Cognitive Function in Patients with Atrial Fibrillation. Medicine (Baltimore). 2021, vol. 100, no. 22, art. e26914. DOI: 10.1097/MD.0000000000026914.
30. Mongkhon P., Fanning L., Lau W.C.Y. et al. Oral Anticoagulant and Reduced Risk of Dementia in Patients with Atrial Fibrillation: A Population-Based Cohort Study. Heart Rhythm. 2020, vol. 17, no. 5(pt A), pp. 706–713. DOI: 10.1016/j.hrthm.2020.01.007.
Review
For citations:
Tsimenava S.V., Snezhitskiy V.A., Kulesh S.D., Liabetskaya A.I., Bros N.A. Cognitive Impairment and Atrial Fibrillation: Epidemiology, Pathophysiological Mechanisms, Risk Factors, and Future Perspectives. Emergency Cardiology and Cardiovascular Risks journal. 2026;10(1):2716-2721. (In Russ.) https://doi.org/10.51922/2616-633X.2026.10.1.2716
Views:
35
JATS XML
Email this article 